26102294|t|Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide.
26102294|a|Tumor cellular senescence induced by genotoxic treatments has recently been found to be paradoxically linked to the induction of "stemness." This observation is critical as it directly impinges upon the response of tumors to current chemo-radio-therapy treatment regimens. Previously, we showed that following etoposide (ETO) treatment embryonal carcinoma PA-1 cells undergo a p53-dependent upregulation of OCT4A and p21Cip1 (governing self-renewal and regulating cell cycle inhibition and senescence, respectively). Here we report further detail on the relationship between these and other critical cell-fate regulators. PA-1 cells treated with ETO display highly heterogeneous increases in OCT4A and p21Cip1 indicative of dis-adaptation catastrophe. Silencing OCT4A suppresses p21Cip1, changes cell cycle regulation and subsequently suppresses terminal senescence; p21Cip1-silencing did not affect OCT4A expression or cellular phenotype. SOX2 and NANOG expression did not change following ETO treatment suggesting a dissociation of OCT4A from its pluripotency function. Instead, ETO-induced OCT4A was concomitant with activation of AMPK, a key component of metabolic stress and autophagy regulation. p16ink4a, the inducer of terminal senescence, underwent autophagic sequestration in the cytoplasm of ETO-treated cells, allowing alternative cell fates. Accordingly, failure of autophagy was accompanied by an accumulation of p16ink4a, nuclear disintegration, and loss of cell recovery. Together, these findings imply that OCT4A induction following DNA damage in PA-1 cells, performs a cell stress, rather than self-renewal, function by moderating the expression of p21Cip1, which alongside AMPK helps to then regulate autophagy. Moreover, this data indicates that exhaustion of autophagy, through persistent DNA damage, is the cause of terminal cellular senescence.
26102294	25	30	OCT4A	GeneOrGeneProduct	5460
26102294	61	80	embryonal carcinoma	DiseaseOrPhenotypicFeature	D018236
26102294	100	109	etoposide	ChemicalEntity	D005047
26102294	326	332	tumors	DiseaseOrPhenotypicFeature	D009369
26102294	421	430	etoposide	ChemicalEntity	D005047
26102294	432	435	ETO	ChemicalEntity	D005047
26102294	447	466	embryonal carcinoma	DiseaseOrPhenotypicFeature	D018236
26102294	467	471	PA-1	CellLine	CVCL_0479
26102294	488	491	p53	GeneOrGeneProduct	7157
26102294	518	523	OCT4A	GeneOrGeneProduct	5460
26102294	528	535	p21Cip1	GeneOrGeneProduct	1026
26102294	733	737	PA-1	CellLine	CVCL_0479
26102294	757	760	ETO	ChemicalEntity	D005047
26102294	803	808	OCT4A	GeneOrGeneProduct	5460
26102294	813	820	p21Cip1	GeneOrGeneProduct	1026
26102294	873	878	OCT4A	GeneOrGeneProduct	5460
26102294	890	897	p21Cip1	GeneOrGeneProduct	1026
26102294	978	985	p21Cip1	GeneOrGeneProduct	1026
26102294	1011	1016	OCT4A	GeneOrGeneProduct	5460
26102294	1051	1055	SOX2	GeneOrGeneProduct	6657
26102294	1060	1065	NANOG	GeneOrGeneProduct	79923
26102294	1102	1105	ETO	ChemicalEntity	D005047
26102294	1145	1150	OCT4A	GeneOrGeneProduct	5460
26102294	1192	1195	ETO	ChemicalEntity	D005047
26102294	1204	1209	OCT4A	GeneOrGeneProduct	5460
26102294	1245	1249	AMPK	GeneOrGeneProduct	5562
26102294	1313	1321	p16ink4a	GeneOrGeneProduct	1029
26102294	1414	1417	ETO	ChemicalEntity	D005047
26102294	1538	1546	p16ink4a	GeneOrGeneProduct	1029
26102294	1635	1640	OCT4A	GeneOrGeneProduct	5460
26102294	1675	1679	PA-1	CellLine	CVCL_0479
26102294	1778	1785	p21Cip1	GeneOrGeneProduct	1026
26102294	1803	1807	AMPK	GeneOrGeneProduct	5562
26102294	Positive_Correlation	7157	1026	No
26102294	Positive_Correlation	7157	5460	No
26102294	Association	D018236	7157	No
26102294	Association	D018236	1026	No
26102294	Association	D018236	5460	No
26102294	Association	1029	D005047	Novel
26102294	Association	D005047	7157	No
26102294	Negative_Correlation	D005047	D018236	No
26102294	Positive_Correlation	D005047	5562	Novel
26102294	Positive_Correlation	D005047	1026	No
26102294	Positive_Correlation	D005047	5460	Novel
26102294	Association	1026	5562	Novel
26102294	Positive_Correlation	5460	5562	Novel
26102294	Positive_Correlation	5460	1026	Novel